PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Tilray Brands, Inc. (TLRY.TO)
2.000.05 (2.56%)
1.90 - 2.15
0.48 - 2.54
9.88M / 2.92M (Avg.)
-0.48 | -4.19
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
114.16%
Net income growth of 114.16% while Healthcare median is zero at 0.00%. Walter Schloss would note a slight edge that could grow if sustained.
94.53%
D&A growth of 94.53% while Healthcare median is zero at 0.00%. Walter Schloss would question intangible or new expansions driving that cost difference.
797.79%
Deferred tax growth of 797.79% while Healthcare median is zero at 0.00%. Walter Schloss would see a difference that might matter for future cash flow if significant.
180.67%
SBC growth of 180.67% while Healthcare median is zero at 0.00%. Walter Schloss would question expansions or staff additions causing more equity grants.
-181.03%
Working capital is shrinking yoy while Healthcare median is 0.00%. Seth Klarman would see an advantage if sales remain robust.
-1.41%
AR shrinks yoy while Healthcare median is 0.00%. Seth Klarman would see an advantage in working capital if sales do not drop.
-432.56%
Inventory shrinks yoy while Healthcare median is 0.00%. Seth Klarman would see a working capital edge if sales hold up.
136819619187916704.00%
AP growth of 136819619187916704.00% while Healthcare median is zero at 0.00%. Walter Schloss would question expansions or credit policies affecting the difference.
-78.19%
Other WC usage shrinks yoy while Healthcare median is 0.00%. Seth Klarman would see an advantage if top-line is stable or growing.
-206.43%
Other non-cash items dropping yoy while Healthcare median is 0.00%. Seth Klarman would see a short-term advantage if real fundamentals remain intact.
-96.29%
Negative CFO growth while Healthcare median is 0.00%. Seth Klarman would suspect a firm-specific operational weakness if peers maintain growth.
-174.60%
CapEx declines yoy while Healthcare median is 0.00%. Seth Klarman would note a short-term FCF advantage if revenue is stable.
65333.79%
Acquisition growth of 65333.79% while Healthcare median is zero at 0.00%. Walter Schloss would question expansions or partial deals fueling that difference.
-596.55%
Investment purchases shrink yoy while Healthcare median is 0.00%. Seth Klarman would see a short-term cash advantage if no high-return opportunities are missed.
-65.46%
We liquidate less yoy while Healthcare median is 0.00%. Seth Klarman would see a firm-specific hold strategy unless missed gains exist.
-52.52%
We reduce “other investing” yoy while Healthcare median is 0.00%. Seth Klarman would see a potential advantage in preserving cash if top-line growth is not harmed.
-869.69%
Reduced investing yoy while Healthcare median is 0.00%. Seth Klarman sees potential advantage in near-term liquidity if revenue remains stable.
-30.32%
Debt repayment yoy declines while Healthcare median is 0.00%. Seth Klarman fears increased leverage if expansions do not yield quick returns.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.